Evidence map›Paper›PMID 39698576›Full record

ReviewTranslational andrology and urology2024

Zhiliang Xia, Dan Du, Zhi Zhang, Zonglai Liu, Zhonggui Hu, Xinyu Li, Xiong Guo, Ziqiu He

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Translational andrology and urology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhiliang XiaDepartment of Urology, Second People's Hospital of China Three Gorges University, Yichang, China.ORCID https://orcid.org/0009-0009-7349-7621
Dan DuDepartment of Urology, Second People's Hospital of China Three Gorges University, Yichang, China.
Zhi ZhangDepartment of Urology, Second People's Hospital of China Three Gorges University, Yichang, China.
Zonglai LiuDepartment of Urology, Second People's Hospital of China Three Gorges University, Yichang, China.
Zhonggui HuDepartment of Urology, Second People's Hospital of China Three Gorges University, Yichang, China.
Xinyu LiDepartment of Urology, Second People's Hospital of China Three Gorges University, Yichang, China.
Xiong GuoDepartment of Urology, Second People's Hospital of China Three Gorges University, Yichang, China.
Ziqiu HeDepartment of Urology, Second People's Hospital of China Three Gorges University, Yichang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: Prostate cancer is a major cause of cancer-related morbidity and mortality in men globally. The pathogenesis involves complex interactions between genetic mutations and environmental factors, activating multiple signaling pathways, especially Wnt/β-catenin, PI3K/Akt, and NF-κB pathways. Tumor suppressor genes Methods: A comprehensive literature review was conducted, examining studies on the molecular biology of Key Content and Findings: Conclusions: The tumor suppressor functions of

Indexed as

biological functionDickkopf-3prostate cancertherapeutic targetsWnt inhibitory factor-1

Identifiers

PMID39698576
PMCPMC11650354

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.